These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4105805)

  • 1. [Hormone analytic studies during therapy with new contraceptive agents].
    Tenhaeff D
    Geburtshilfe Frauenheilkd; 1971 Aug; 31(8):760-7. PubMed ID: 4105805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunochemical determination of LH during therapy with oral and depot contraceptives].
    Tenhaeff D
    Arch Gynakol; 1971 Jun; 211(1):232. PubMed ID: 4103780
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proceedings: Hormone excretion and cyclus course in various low dosage progestational hormones].
    Tenhaeff D
    Arch Gynakol; 1973 Sep; 214(1):267-8. PubMed ID: 4130936
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of ethinylestrenol and mestranol as a contraceptive.
    Kaltreider DF
    Fertil Steril; 1968; 19(4):589-92. PubMed ID: 5660243
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative cytological and histological studies following the use of an ovulation inhibiting estrogen-gestagen combination (Ovositon)].
    Krause W; Böhm W; Müller W
    Gynaecologia; 1968; 166(5):432-45. PubMed ID: 4179218
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a new sequential contraceptive agent.
    Parkinson RW; McQuarrie HG; Ellsworth HS; Stone RA
    Obstet Gynecol; 1966 Aug; 28(2):239-46. PubMed ID: 4161460
    [No Abstract]   [Full Text] [Related]  

  • 7. [LH excretion during the ovulatory cycle and during therapy with various estrogen-gestagen combinations].
    Göretzlehner G; Wilken H
    Endokrinologie; 1972 Nov; 60(3):302-8. PubMed ID: 4121480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OVARIAN INHIBITION WITH PROGESTOGENS: A STUDY OF THE RECUPERATION STAGE.
    PEETERS F; OEYEN R; VANROY M
    Int J Fertil; 1964; 9():111-20. PubMed ID: 14106241
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of various dosages of lynestrenol on the FSH, LH and total gonadotrophin activity during the menstrual cycle.
    Schmidt-Elmendorff H
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):368-73. PubMed ID: 5510165
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary hormone excretion patterns during low-dose progestogen administration.
    Varga L; Tamme E
    J Int Med Res; 1975; 3(2):63-72. PubMed ID: 1140508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gas chromatography of oral progestagens and estrogens.
    Prous JR; Sussmann AR
    Med Actual; 1968; 4(2):56-7. PubMed ID: 12334354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical results of administration of gestagens (Anovlar 21 and Lyndiol 2,5) in endometriosis].
    Laudańska E
    Ginekol Pol; 1968 Sep; 39(9):1015-20. PubMed ID: 4881514
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of ovulation by estrogens.
    Gual C; Becerra C; Rice-Wray E; Goldzieher JW
    Am J Obstet Gynecol; 1967 Feb; 97(4):443-7. PubMed ID: 4163201
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of a low-oestrogen oral contraceptive on urinary excretion of luteinizing hormone and ovarian steroids.
    Elstein M; Briston PG; Jenkins M; Kirk D; Miller H
    Br Med J; 1974 Jan; 1(5896):11-3. PubMed ID: 4808812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological inhibition of ovulation].
    Haller J
    Fortschr Geburtshilfe Gynakol (1950); 1965; 21():37-106. PubMed ID: 12255694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism in inhibition of ovulation in oral contraception. 3. The excretion of total pituitary gonadotrophins and luteinizing hormone in fertile women during cyclical treatment with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone together with 17-alpha-ethynyl-oestradinol-3-methylether.
    Starup J; Lebech PE
    Acta Endocrinol (Copenh); 1967 Oct; 56(2):188-96. PubMed ID: 6072686
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical therapy of acne vulgaris].
    Naerup JG
    Tidsskr Nor Laegeforen; 1968 Apr; 88(7):650. PubMed ID: 4175244
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormonal therapy of acne vulgaris. Ovulation inhibitors in premenstrual acne].
    Schirren C; Immel L
    Munch Med Wochenschr; 1969 Aug; 111(35):1742-7. PubMed ID: 4185512
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sequential therapy].
    Annee Endocrinol; 1967; 19():97-102. PubMed ID: 4173491
    [No Abstract]   [Full Text] [Related]  

  • 20. [The therapeutic use of the sequentially administered oral ovulation inhibitor Ovanon].
    Gimes R; Tóth F
    Dtsch Med J; 1969 Dec; 20(23):718-9. PubMed ID: 5397037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.